Skip to main content

Value-Based Care in Cardiometabolic Health May 2012, Vol 1, No 1

Low-Potency Statins Initiated in High-Risk Patients in a Managed Care Setting

New Drug Therapies for Difficult-to-Control Atrial Fibrillation

Cardiac Resynchronization Therapy Still Challenging in Patients with Atrial Fibrillation and Heart Failure

Dabigatran Safe and Effective Anticoagulant Postablation in Patients with Atrial Fibrillation

Blood Assay for Galectin-3 Identifies Heart Failure Risk of Patients in the Community Setting

Advances in Stem-Cell Therapy for Heart Failure

Comparative Effectiveness Analysis: Emergency Department CTA versus Standard ACS Symptom Evaluation

IMMEDIATE: Early Use of Inexpensive Glucose-Insulin- Potassium Solution Can Prevent Cardiac Arrest in ACS

Value of New Anticoagulants in Acute Coronary Syndrome Still Unclear

New JNC-8 Hypertension Guidelines to Be Released by Year End

Page 2 of 3
Results 11 - 20 of 30